These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 30415236)
21. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease. Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633 [TBL] [Abstract][Full Text] [Related]
22. Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. Undas A; Brummel-Ziedins K; Mann KG J Thromb Haemost; 2014 Nov; 12(11):1776-87. PubMed ID: 25213262 [TBL] [Abstract][Full Text] [Related]
23. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation. Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596 [TBL] [Abstract][Full Text] [Related]
24. Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implications. Undas A Europace; 2020 Feb; 22(2):185-194. PubMed ID: 31625555 [TBL] [Abstract][Full Text] [Related]
25. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Undas A; Ariëns RA Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e88-99. PubMed ID: 21836064 [TBL] [Abstract][Full Text] [Related]
26. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890 [TBL] [Abstract][Full Text] [Related]
27. Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy. Nastałek M; Wojas-Pelc A; Undas A J Thromb Thrombolysis; 2010 Aug; 30(2):121-6. PubMed ID: 20419337 [TBL] [Abstract][Full Text] [Related]
28. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism. Owczarek D; Cibor D; Sałapa K; Głowacki MK; Mach T; Undas A Inflamm Bowel Dis; 2013 Nov; 19(12):2616-24. PubMed ID: 24108112 [TBL] [Abstract][Full Text] [Related]
29. Fibrin clot properties and their modulation in thrombotic disorders. Undas A Thromb Haemost; 2014 Jul; 112(1):32-42. PubMed ID: 24671700 [TBL] [Abstract][Full Text] [Related]
30. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Konieczynska M; Fil K; Bazanek M; Undas A Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139 [TBL] [Abstract][Full Text] [Related]
32. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality. Undas A; Kolarz M; Kopeć G; Tracz W Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458 [TBL] [Abstract][Full Text] [Related]
33. Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence. Undas A Biomed Res Int; 2017; 2017():8196256. PubMed ID: 28740853 [TBL] [Abstract][Full Text] [Related]
34. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges. Gaule TG; Ajjan RA Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139 [TBL] [Abstract][Full Text] [Related]
35. Altered plasma fibrin clot properties in essential thrombocythemia. Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A Platelets; 2016; 27(2):110-6. PubMed ID: 25989112 [TBL] [Abstract][Full Text] [Related]
36. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications. Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680 [TBL] [Abstract][Full Text] [Related]
37. Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment. Jóźwik-Plebanek K; Prejbisz A; Wypasek E; Pręgowska-Chwała B; Hanus K; Kaszuba AM; Januszewicz M; Bieleń P; Kabat M; Kruk M; Dobrowolski P; Klisiewicz A; Śliwiński P; Januszewicz A; Undas A J Hypertens; 2017 May; 35(5):1035-1043. PubMed ID: 28141659 [TBL] [Abstract][Full Text] [Related]
38. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin. Lau YC; Xiong Q; Lip GY; Blann AD Ann Med; 2016; 48(4):275-81. PubMed ID: 27043881 [TBL] [Abstract][Full Text] [Related]
39. Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation. Lau YC; Xiong Q; Shantsila E; Lip GY; Blann AD J Thromb Thrombolysis; 2016 Nov; 42(4):535-44. PubMed ID: 27554264 [TBL] [Abstract][Full Text] [Related]
40. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban. Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]